as expected: minimal dilution and funds to be used for growth...

as expected: minimal dilution and funds to be used for growth and working capital.

the company surely now is at or very near critical mass, such that changes to critical metrics will add real weight rather than just being incremental.

CEO Dr Arango is optimistic, as per below.

in a statement to ASX "IMEXHS Founder and CEO, Dr German Arango said: “We appreciate the support we have had on this raise. The funds enable us to fund growth most particularly working capital. The business is travelling well, and I am confident that we will deliver a strong result in 2024.”